WAKE AND LIVE –
Jan. 30, 2021 – “Our findings suggest that higher storefront cannabis dispensary counts are associated with reduced opioid-related mortality rates at the county level,” the authors write. “While the associations documented cannot be assumed to be causal, they suggest a potential association between increased prevalence of medical and recreational cannabis dispensaries and reduced opioid-related mortality rates.” The study by Greta Hsu, at the University of California, Davis, and Balázs Kovács, at Yale University, was published this week in The BMJ, a respected medical journal previous known as the British Medical Journal. It follows a Canadian study published this week that found legalizing cannabis led to a “marked decline” in the volume of opioids prescribed across Canada.
